The development of new technology is playing a pivotal role in the advancement of both patient autonomy and drug development. It’s a huge challenge for regulators to ensure drugs being manufactured are adhering to uniform standards of quality and safety. In this online exclusive, Graham Francis, product marketing manager at Kallik, explains how data integrity should be a top priority when using new technologies in the pharmaceutical industry.
digital drug
More drugs are being developed and manufactured in laboratories than ever before. This not only increases scrutiny of drug submissions and releasing data for compliance, but drugs need to be created as safely and securely possible.